107 related articles for article (PubMed ID: 28523851)
1. Identification of Multiple Druggable Secondary Sites by Fragment Screening against DC-SIGN.
Aretz J; Baukmann H; Shanina E; Hanske J; Wawrzinek R; Zapol'skii VA; Seeberger PH; Kaufmann DE; Rademacher C
Angew Chem Int Ed Engl; 2017 Jun; 56(25):7292-7296. PubMed ID: 28523851
[TBL] [Abstract][Full Text] [Related]
2. Docking, synthesis, and NMR studies of mannosyl trisaccharide ligands for DC-SIGN lectin.
Reina JJ; Díaz I; Nieto PM; Campillo NE; Páez JA; Tabarani G; Fieschi F; Rojo J
Org Biomol Chem; 2008 Aug; 6(15):2743-54. PubMed ID: 18633532
[TBL] [Abstract][Full Text] [Related]
3. Non-carbohydrate inhibitors of the lectin DC-SIGN.
Borrok MJ; Kiessling LL
J Am Chem Soc; 2007 Oct; 129(42):12780-5. PubMed ID: 17902657
[TBL] [Abstract][Full Text] [Related]
4. Mannosylcalix[n]arenes as multivalent ligands for DC-SIGN.
Morbioli I; Porkolab V; Magini A; Casnati A; Fieschi F; Sansone F
Carbohydr Res; 2017 Dec; 453-454():36-43. PubMed ID: 29121497
[TBL] [Abstract][Full Text] [Related]
5. Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design.
Thépaut M; Guzzi C; Sutkeviciute I; Sattin S; Ribeiro-Viana R; Varga N; Chabrol E; Rojo J; Bernardi A; Angulo J; Nieto PM; Fieschi F
J Am Chem Soc; 2013 Feb; 135(7):2518-29. PubMed ID: 23360500
[TBL] [Abstract][Full Text] [Related]
6. Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside.
Varga N; Sutkeviciute I; Guzzi C; McGeagh J; Petit-Haertlein I; Gugliotta S; Weiser J; Angulo J; Fieschi F; Bernardi A
Chemistry; 2013 Apr; 19(15):4786-97. PubMed ID: 23417900
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of novel DC-SIGN ligands with an alpha-fucosylamide anchor.
Timpano G; Tabarani G; Anderluh M; Invernizzi D; Vasile F; Potenza D; Nieto PM; Rojo J; Fieschi F; Bernardi A
Chembiochem; 2008 Aug; 9(12):1921-30. PubMed ID: 18655085
[TBL] [Abstract][Full Text] [Related]
8. 1,2-Mannobioside mimic: synthesis, DC-SIGN interaction by NMR and docking, and antiviral activity.
Reina JJ; Sattin S; Invernizzi D; Mari S; Martínez-Prats L; Tabarani G; Fieschi F; Delgado R; Nieto PM; Rojo J; Bernardi A
ChemMedChem; 2007 Jul; 2(7):1030-6. PubMed ID: 17508368
[TBL] [Abstract][Full Text] [Related]
9. Mannose glycoconjugates functionalized at positions 1 and 6. Binding analysis to DC-SIGN using biosensors.
Reina JJ; Maldonado OS; Tabarani G; Fieschi F; Rojo J
Bioconjug Chem; 2007; 18(3):963-9. PubMed ID: 17348701
[TBL] [Abstract][Full Text] [Related]
10. Detection and quantitative analysis of two independent binding modes of a small ligand responsible for DC-SIGN clustering.
Guzzi C; Alfarano P; Sutkeviciute I; Sattin S; Ribeiro-Viana R; Fieschi F; Bernardi A; Weiser J; Rojo J; Angulo J; Nieto PM
Org Biomol Chem; 2016 Jan; 14(1):335-44. PubMed ID: 26611567
[TBL] [Abstract][Full Text] [Related]
11. STD NMR and molecular modelling insights into interaction of novel mannose-based ligands with DC-SIGN.
Kotar A; Tomašič T; Lenarčič Živković M; Jug G; Plavec J; Anderluh M
Org Biomol Chem; 2016 Jan; 14(3):862-75. PubMed ID: 26580315
[TBL] [Abstract][Full Text] [Related]
12. CellFy: A Cell-Based Fragment Screen against C-Type Lectins.
Schulze J; Baukmann H; Wawrzinek R; Fuchsberger FF; Specker E; Aretz J; Nazaré M; Rademacher C
ACS Chem Biol; 2018 Dec; 13(12):3229-3235. PubMed ID: 30480432
[TBL] [Abstract][Full Text] [Related]
13. Development of C-type lectin-oriented surfaces for high avidity glycoconjugates: towards mimicking multivalent interactions on the cell surface.
Porkolab V; Pifferi C; Sutkeviciute I; Ordanini S; Taouai M; Thépaut M; Vivès C; Benazza M; Bernardi A; Renaudet O; Fieschi F
Org Biomol Chem; 2020 Jul; 18(25):4763-4772. PubMed ID: 32608454
[TBL] [Abstract][Full Text] [Related]
14. Unraveling Sugar Binding Modes to DC-SIGN by Employing Fluorinated Carbohydrates.
Martínez JD; Valverde P; Delgado S; Romanò C; Linclau B; Reichardt NC; Oscarson S; Ardá A; Jiménez-Barbero J; Cañada FJ
Molecules; 2019 Jun; 24(12):. PubMed ID: 31242623
[TBL] [Abstract][Full Text] [Related]
15. Structural characterization of the DC-SIGN-Lewis(X) complex.
Pederson K; Mitchell DA; Prestegard JH
Biochemistry; 2014 Sep; 53(35):5700-9. PubMed ID: 25121780
[TBL] [Abstract][Full Text] [Related]
16. Saturation transfer difference (STD) NMR spectroscopy characterization of dual binding mode of a mannose disaccharide to DC-SIGN.
Angulo J; Díaz I; Reina JJ; Tabarani G; Fieschi F; Rojo J; Nieto PM
Chembiochem; 2008 Sep; 9(14):2225-7. PubMed ID: 18720494
[No Abstract] [Full Text] [Related]
17. Comparative evaluation of several docking tools for docking small molecule ligands to DC-SIGN.
Jug G; Anderluh M; Tomašič T
J Mol Model; 2015 Jun; 21(6):164. PubMed ID: 26040678
[TBL] [Abstract][Full Text] [Related]
18. Genetically-encoded fragment-based discovery of glycopeptide ligands for DC-SIGN.
Ng S; Bennett NJ; Schulze J; Gao N; Rademacher C; Derda R
Bioorg Med Chem; 2018 Oct; 26(19):5368-5377. PubMed ID: 30344001
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.
Holla A; Skerra A
Protein Eng Des Sel; 2011 Sep; 24(9):659-69. PubMed ID: 21540232
[TBL] [Abstract][Full Text] [Related]
20. Oligomerization domains in the glycan-binding receptors DC-SIGN and DC-SIGNR: Sequence variation and stability differences.
Dos Santos Á; Hadjivasiliou A; Ossa F; Lim NK; Turgut A; Taylor ME; Drickamer K
Protein Sci; 2017 Feb; 26(2):306-316. PubMed ID: 27859859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
